NEWS
FDA drug approval lifts biotech Neuren to $1b valuation
MELBOURNE: Biotech Neuren Pharmaceuticals surged to a $1 billion valuation yesterday after the US healthcare… read more
19 new senior healthcare executives sought for key roles
MELBOURNE: Nineteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more